Friday, November 22, 2024
HomeTagsNeovascular

neovascular

FDA approves Roche’s Vabysmo prefilled syringe (PFS) for three leading causes of vision loss

Roche announced the United States Food and Drug Administration (US FDA) has approved the Vabysmo 6.0 mg single-dose prefilled syringe (PFS) for use in...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics